OSE-279

· OSE Immunotherapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for OSE-279, covering 2026-01-28 to 2026-01-28. Get the full timeline:

Most recent: Clinical Trial Update: Dose-finding and Dose Expansion Study of OSE-279 in Subjects With Advanced Solid Tumors or Lymphomas [Phase 1, Phase 2]

See pricing